Edition:
United Kingdom

NxStage Medical Inc (NXTM.OQ)

NXTM.OQ on NASDAQ Stock Exchange Global Select Market

25.99USD
17 Nov 2017
Change (% chg)

$0.11 (+0.43%)
Prev Close
$25.88
Open
$25.75
Day's High
$26.03
Day's Low
$25.75
Volume
95,464
Avg. Vol
274,005
52-wk High
$30.80
52-wk Low
$20.47

Select another date:

Fri, Oct 27 2017

BRIEF-NXSTAGE SAYS STOCKHOLDER APPROVE MERGER WITH FRESENIUS MEDICAL CARE

* NXSTAGE ANNOUNCES STOCKHOLDER APPROVAL OF MERGER AGREEMENT WITH FRESENIUS MEDICAL CARE

BRIEF-NxStage Medical announces FDA clearance for solo home hemodialysis using NxStage system one

* NxStage Medical announces FDA clearance for solo home hemodialysis using NxStage® system one™

BRIEF-Nxstage Medical Inc says subsidiary is partnering with Dialyze Direct​

* ‍Nxstage kidney care subsidiary is partnering with Dialyze Direct​ Source text for Eikon: Further company coverage:

Fresenius Medical banks on home dialysis with $2 billion NxStage acquisition

FRANKFURT Germany's Fresenius Medical Care (FMC) has struck a $2 billion deal to acquire U.S. home dialysis equipment maker NxStage Medical Inc , looking to capitalize on a trend for more patients to opt for domestic treatment.

UPDATE 3-Fresenius Medical banks on home dialysis with $2 bln NxStage acquisition

* FMC shares down more than 2pct, biggest DAX losers (Rewrites first paragraph, adds background on shift to home dialysis and FMC's previous acquisitions, CEO quote)

BRIEF-NxStage Medical posts Q2 loss of $0.03 per share

* NxStage Medical - in light of acquisition agreement between Fresenius Medical Care and NxStage, NxStage is no longer providing financial guidance

Germany's FMC to buy U.S. home dialysis firm NxStage for $2 billion

FRANKFURT German dialysis services provider Fresenius Medical Care (FMC) said on Monday it has agreed to buy for around $2 billion (1.53 billion pounds) in cash NxStage , a U.S. maker of devices for use in home dialysis.

Select another date: